Genome Medical Genome Medical, Hereditary Neuropathy Foundation Partner for Charcot-Marie-Tooth Disease Testing The CMT Genie Project aims to provide faster and more equitable access to genetic testing for the CMT community via virtual services. Seven Bridges Genomics to Foster Partnerships Between Health Systems, Pharmas With New Subsidiary Premium The Unified Patient Network expects pharmaceutical companies to sponsor whole-genome sequencing for patients from health systems for research and clinical purposes. Genome Medical Raises $60M in Series C Round, to Acquire Telehealth Firm GeneMatters GeneMatters provides genetic counseling, care delivery software, and patient engagement tools and will become a subsidiary of Genome Medical. Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy The testing program will be available for patients in the US who have symptoms or a diagnosis of cerebral palsy but no evidence of brain injury. Genome Medical Raises $14M in Extended Series B Financing The company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform. Breaking News Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics International Commission to Expand Molecular Testing Access for Cancer Patients NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test SomaLogic Expands Into Middle East With Proteomics Supply Deal for Group 42 Healthcare Arima Genomics to Offer NGS-Based Gene Fusion Test Through Protean BioDiagnostics CLIA Lab The Scan Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline. Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine. Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures. Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.